FREE NEJM E-TOC    HOME   |   SUBSCRIBE   |   CURRENT ISSUE   |   PAST ISSUES   |   COLLECTIONS   |   Search Term  Advanced Search

Sign in | Get NEJM's E-Mail Table of Contents — Free | Subscribe

Previous Volume 351:937-938 August 26, 2004 Number 9 Next

	Since this article has no abstract, we have provided an extract of the first 100 words of the full text and any section headings.

	Full Text PDF PDA Full Text Purchase this article Add to Personal Archive Add to Citation Manager Notify a Friend E-mail When Cited E-mail When Letters Appear Related Article Related Article Related Article by Olsen, N. J. Related Article by O'Dell, J. R. PubMed Citation

To the Editor: In an examination of the data that support the use of anti–tumor necrosis factor (TNF) drugs for rheumatoid arthritis, as reviewed by O'Dell (June 17 issue)¹ and by Olsen and Stein (May 20 issue),² one critical point is that there has been just a single randomized trial of infliximab and adalimumab (in which the new agent plus methotrexate was compared with methotrexate alone) and there have been only two trials of etanercept (one very recent³ and therefore not mentioned by Olsen and Stein). In addition, the number of patients enrolled in these trials was small (the number . . . [Full Text of this Article]

Related Letters:

Rheumatoid Arthritis
Burchini G., Orsi C., Bhattacharya N., O'Dell J. R.
Extract | Full Text | PDF  
N Engl J Med 2004; 351:1360-1361, Sep 23, 2004. Correspondence

New Drugs for Rheumatoid Arthritis
Roberts L. J., Kalil A. C., Messori A., Santarlasci B., Vaiani M.
Extract | Full Text | PDF  
N Engl J Med 2004; 351:2659-2661, Dec 16, 2004. Correspondence

This article has been cited by other articles:

• Roberts, L. J., Kalil, A. C., Messori, A., Santarlasci, B., Vaiani, M. (2004). New Drugs for Rheumatoid Arthritis. NEJM 351: 2659-2661 [Full Text]  
• Burchini, G., Orsi, C., Bhattacharya, N., O'Dell, J. R. (2004). Rheumatoid Arthritis. NEJM 351: 1360-1361 [Full Text]